Could a Pre-Surgery immune drug shrink early lung cancer nodules?
Disease control
Completed
This pilot study tested the drug Tislelizumab given before surgery in 12 people with early-stage lung cancer who also had multiple ground-glass nodules on CT scans. The goal was to see if the drug could shrink tumors before removal. Researchers measured how many patients responde…
Phase: PHASE2 • Sponsor: XiangNing Fu • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC